Inactive Instrument
Crescita Therapeutics Inc. Stock
Stocks
CTX
CA2258471028
Personal Products
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Serge Verreault
CEO | Chief Executive Officer | - | 2018-04-01 |
Jose DaRocha
DFI | Director of Finance/CFO | - | 2017-11-06 |
Wade Hull
CTO | Chief Tech/Sci/R&D Officer | - | 2016-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Chicoine
CHM | Chairman | 72 | 2016-02-29 |
| Director/Board Member | - | 2016-02-29 | |
John London
BRD | Director/Board Member | - | 2016-02-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Marche | Chairman | -116,227 | 0.6244% | ||
| 6/3/26 | Marche | Director | -58,500 | 0.3143% | ||
| 6/3/26 | Marche | Director | -30,188 | 0.1622% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +5.33% | - | - | 10.56M | |
| +0.61% | +0.34% | +8.02% | +8.25% | 374B | |
| +2.93% | +0.15% | +18.95% | +11.45% | 260B | |
| +2.07% | -1.36% | -6.01% | +12.09% | 141B | |
| +2.29% | +1.33% | +24.55% | +28.98% | 75.96B | |
| +1.66% | +0.94% | +30.75% | - | 54.59B | |
| +0.34% | +2.75% | -24.50% | -24.78% | 46.14B | |
| +0.39% | +0.52% | +11.90% | -14.64% | 39.52B | |
| -1.28% | -1.33% | +35.60% | +3.59% | 37.11B | |
| -1.89% | -2.01% | -10.21% | -9.69% | 35.9B | |
| Average | +0.76% | +0.15% | +9.89% | +1.91% | 118.22B | |
| Weighted average by Cap. | +1.53% | +0.14% | +10.26% | +7.95% |
Employees
65
Sector
Personal Products
